While 55.9% of Americans are fully vaccinated and 64% of Americans have received at least 1 dose of a vaccine, only 31% of pregnant individuals have been fully vaccinated. The CDC urges health care providers to convince pregnant women to get vaccinated.
Health care professionals need to redouble efforts to motivate pregnant women in the United States to get the COVID-19 vaccine, according to an urgent health advisory issued by the Centers for Disease Control and Prevention (CDC).
According to Our World in Data, an information gathering organization out of the University of Oxford, 55.9% of Americans are fully vaccinated, while 64% of Americans have received at least 1 dose of a vaccine. Meanwhile, according to the CDC, only 31% of pregnant individuals have been fully vaccinated.
The advisory, which was issued Wednesday, alludes to the possible misinformation that may be causing vaccine hesitancy among pregnant individuals, saying that “there is currently no evidence” that the COVID-19 vaccines cause infertility. The advisory includes steps that health care providers should take when treating or interacting with women who are pregnant or plan to become pregnant. Health care providers should:
“A strong recommendation from a health care provider is a critical factor in COVID-19 vaccine acceptance and can make a meaningful difference to protect the health of pregnant and recently pregnant people and their fetuses/infants from COVID-19,” the CDC advisory states.
Significant disparities in COVID-19 vaccine uptake exist among different ethnic and racial groups: Asian-Americans (45.7%), Latinos (25%), Blacks (15.6%).
“Efforts should specifically address populations with lower vaccination coverage and use approaches to reduce racial and ethnic disparities,” the CDC advisory states. “CDC recommends ensuring tailored, culturally responsive, and linguistically appropriate communication of vaccination benefits.”
As of Monday, there have been more than 125,000 confirmed COVID-19 cases in pregnant individuals that resulted in about 22,000 hospitalizations and 161 deaths, according to the CDC.
“Pregnant and recently pregnant people with COVID-19 are at increased risk for severe illness when compared with non-pregnant people,” the CDC advisory states. “Severe illness includes illness that requires hospitalization, intensive care unit (ICU) admission, mechanical ventilation, or extracorporeal membrane oxygenation (ECMO), or illness that results in death. Although the absolute risk is low, compared with non-pregnant symptomatic people, symptomatic pregnant people have more than a two-fold increased risk of requiring ICU admission, invasive ventilation, and ECMO, and a 70% increased risk of death.”
Public health departments also need to get more involved. The CDC recommends that they:
An article on September 14 in Infection Control Today®’s sister publication, Contagion®, puts the danger COVID-19 poses to unvaccinated pregnant individuals in context. That article looks at a study in BMC Public Health that found that in Mexico, COVID-19 was the leading cause of maternal death, with 22.93% confirmed, and 4.5% unconfirmed. Data show that 1056 maternal deaths occurred during the study period. But, as Contagion® notes, the study period took place before the availability of COVID-19 vaccines in Mexico, and that the coming availability of vaccines should ameliorate maternal mortality rates in that country.
That’s if pregnant individuals get the vaccine, and as the CDC advisory notes about what's going on in the US, that’s a big if at the moment.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.